期刊文献+

Mechanism of Suppression on Proliferation of QGY Cell by Oxaliplatin

Mechanism of Suppression on Proliferation of QGY Cell by Oxaliplatin
下载PDF
导出
摘要 Objective: To observe the effects of oxaliplatin(L-OHP) on proliferation of human hepatoma cell line QGY in vitro and to investigate the mechanism. Methods: The inhibition of proliferation in QGY cell was assayed by MTT-test. Morphologic changes were observed under light microscope and electronic microscope. Distribution of cell cycle and apoptosis were analyzed using flow cytometry. The expressions of cell cycle proteins and apoptosis-associated proteins were detected with immuno-histochemical technique. Results: Oxaliplatin could inhibit the proliferation of QGY cells and the inhibition depended on the exposure time and dose. The cells showed morphologic changes of the early stage of apoptosis under the light microscope: the shrunk round cells, condensed cytoplasma and pycnosis of nucleus. Apoptotic cells and apoptotic body could be found under the transmission electronic microscope. The analysis of cell cycle indicated that oxaliplatin blocked cells at S and G2/M phases and the cells of G0/G1 phase reduced. When treated with oxaliplatin for 72h, the expressions of cyclin A and Bax were up-regulated, mutant type P53, Bcl-2 and Myc were down-regulated, and Fas was not changed. Conclusion: Oxaliplatin could inhibit the proliferation of the hepatoma cell lines. Cells were blocked at S and G2/M phases. The apoptosis was related to the up-regulation of Bax and down-regulation of mutant type P53, Bcl-2 and Myc. Oxaliplatin could not induce apoptosis through the Fas pathway. Objective: To observe the effects of oxaliplatin(L-OHP) on proliferation of human hepatoma cell line QGY in vitro and to investigate the mechanism. Methods: The inhibition of proliferation in QGY cell was assayed by MTT-test. Morphologic changes were observed under light microscope and electronic microscope. Distribution of cell cycle and apoptosis were analyzed using flow cytometry. The expressions of cell cycle proteins and apoptosis-associated proteins were detected with immuno-histochemical technique. Results: Oxaliplatin could inhibit the proliferation of QGY cells and the inhibition depended on the exposure time and dose. The cells showed morphologic changes of the early stage of apoptosis under the light microscope: the shrunk round cells, condensed cytoplasma and pycnosis of nucleus. Apoptotic cells and apoptotic body could be found under the transmission electronic microscope. The analysis of cell cycle indicated that oxaliplatin blocked cells at S and G2/M phases and the cells of G0/G1 phase reduced. When treated with oxaliplatin for 72h, the expressions of cyclin A and Bax were up-regulated, mutant type P53, Bcl-2 and Myc were down-regulated, and Fas was not changed. Conclusion: Oxaliplatin could inhibit the proliferation of the hepatoma cell lines. Cells were blocked at S and G2/M phases. The apoptosis was related to the up-regulation of Bax and down-regulation of mutant type P53, Bcl-2 and Myc. Oxaliplatin could not induce apoptosis through the Fas pathway.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2007年第4期263-268,共6页 中国癌症研究(英文版)
基金 This work was supported by the key program for the Science & Tchnology Research of Health Bureau of Chongqing Municipality(No.200101-1-018).
关键词 OXALIPLATIN Hepatocellularcarcinoma PROLIFERATION Oxaliplatin Hepatocellularcarcinoma Proliferation
  • 相关文献

参考文献1

二级参考文献43

  • 1Fishman P. Role of membrane gangliosides in the binding and action of bacterial toxins. J Membr Biol 1982; 69:85-97.
  • 2Griffiths SL, Finkelstein RA, Critchley DR. Characterization of the receptor for cholera toxin and Escherichia coli heat-labile toxin in rabbit intestinal brush borders. Biochem J 1986; 238:313-322.
  • 3Holmgren J, Lindblad H, Fredman P, Svennerholm L, Myrvold A. Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology 1985; 89:27-35.
  • 4Nakamura K, Suzuki M, lnagaki F, Yamakawa T, Suzuki A. A new ganglioside showing cholera genoid-binding activity in mousespleen. J Biochem 1987; 101:825-835.
  • 5Pacuszka T, Bradley RM, Fishman PH. Neoglycolipid analogues of ganglioside GM1 as functional receptors of cholera toxin.Biochemistry 1991; 30:2563-2570.
  • 6Smets LA, Van Roy H. Mitogenic and anti-mitogenic effect of cholera toxin-mediated cyclic AMP levels in 3T3 cells. J Cell Physiol 1987; 133:395-399.
  • 7Rozengurt E, Legg A, Strang G, Courtenay-Luck N. Cyclic AMP:a mitogenic signal for Swiss 3T3 cells. Proc Natl Acad Sci U S A 1981; 78:4392-4396.
  • 8Enomoto K, Gill DM. Cholera toxin activation of adenylatecyclase. Biol Chem 1980; 255:1252-1258.
  • 9Anderson DL, Tsoukas CD. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway. J lmmunol 1989; 43:3642-3647.
  • 10Chang FH, Bourne HR. Cholera toxin induces cAMP-independent degradation of Gs. J Biol Chem 1989; 264:5352-5357.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部